PD-L1 POSITIVE
Clinical trials for PD-L1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PD-L1 POSITIVE trials appear
Sign up with your email to follow new studies for PD-L1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets Tough-to-Treat breast cancer
Disease control Not yet recruitingThis study is testing a new combination of two drugs as a first treatment for people with a specific, hard-to-treat type of advanced breast cancer. It aims to see if the combination is effective and safe for patients whose cancer has spread and cannot be removed by surgery. The t…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
New hope for Tough-to-Treat breast cancer: experimental combo targets tumors
Disease control Not yet recruitingThis study is testing whether combining two drugs—sacituzumab tirumotecan and tagitanlimab—can help control advanced triple-negative breast cancer that has a specific marker (PD-L1 positive) and has worsened after initial treatment. It will involve about 47 adults whose cancer ca…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC